SynthesisJAMA network open2025

Adverse Event Costs and Cost-Effectiveness Analyses of Anticancer Drugs: A Systematic Review.

Mingye Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.